<p>SurgePays, Inc.（纳斯达克代码：SURG - 获取免费报告）在十月份的空头头寸大幅减少。截至 10 月 15 日，空头头寸总计为 163,900 股，较 9 月 30 日的 282,900 股减少了 42.1%。目前，该股票的 1.3% 股份被做空。根据 118,900 股的平均交易量，当前的空头头寸比率为 1.4 天。</p>
<h2>SurgePays 股价下跌 2.9%</h2>
<ul>
<li>便士股票 SurgePays 上涨 70%：买入的一个理由，卖出的五个理由</li>
</ul>
<p>SurgePays 股票在周五的午盘交易中下跌了 0.08 美元，跌至 2.64 美元。该股票的交易量为 95,430 股，而其平均交易量为 107,193 股。该公司的 50 日移动平均线为 2.79 美元，200 日移动平均线为 2.83 美元。SurgePays 的 12 个月低点为 1.05 美元，12 个月高点为 3.47 美元。该公司的速动比率为 0.84，流动比率为 1.11，债务股本比率为 101.87。该公司的市值为 5394 万美元，市盈率为-1.06，贝塔值为 0.43。</p>
<p>SurgePays（纳斯达克代码：SURG - 获取免费报告）最近一次发布季度财报是在 8 月 13 日。该医疗设备提供商报告的每股收益为（0.36 美元），低于市场共识预期的（0.31 美元），差距为（0.05 美元）。SurgePays 的净利润率为负 133.85%，股本回报率为负 333.87%。该公司在本季度的收入为 1152 万美元，而分析师预期为 1614 万美元。SurgePays 已将其 2025 财年的每股收益指引设定为负值。卖方分析师预测 SurgePays 在当前年度的每股收益将为-1.66 美元。</p>
<h2>SurgePays 的机构交易</h2>
<p>几家对冲基金最近对该公司的持仓进行了调整。James Investment Research Inc.在第三季度将其在 SurgePays 的股份增加了 71.1%。James Investment Research Inc.目前拥有 32,500 股该医疗设备提供商的股票，价值 91,000 美元，此前在此期间又购买了 13,500 股。Gerber LLC 在第三季度购买了 SurgePays 的新股份，价值约 38,000 美元。Jane Street Group LLC 在第二季度购买了 SurgePays 的新股份，价值约 42,000 美元。NewEdge Advisors LLC 在第二季度将其在 SurgePays 的持仓增加了 46.2%。NewEdge Advisors LLC 目前拥有 19,000 股该医疗设备提供商的股票，价值 59,000 美元，此前在此期间又购买了 6,000 股。最后，XTX Topco Ltd 在第二季度购买了 SurgePays 的新股份，价值约 125,000 美元。对冲基金和其他机构投资者持有该公司 6.94% 的股份。</p>
<h2>华尔街分析师预测增长</h2>
<p>一些股票研究分析师最近对 SURG 股票发布了报告。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 SurgePays 的 “卖出（e+）” 评级。Ascendiant Capital Markets 在 10 月 3 日的报告中将 SurgePays 的目标价从 9.00 美元上调至 9.50 美元，并给予该公司 “买入” 评级。最后，Wall Street Zen 在 8 月 30 日的报告中将 SurgePays 的评级从 “卖出” 上调至 “持有”。一位研究分析师对该股票给予了买入评级，另一位则给予了卖出评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “持有”，平均目标价为 9.50 美元。</p>
<p><strong>阅读我们最新的 SURG 股票分析</strong></p>
<h2>SurgePays 公司简介</h2>
<p>（获取免费报告）</p>
<p>SurgePays, Inc 及其子公司在美国作为一家金融科技和电信公司运营。它通过三个部门运营：移动虚拟网络运营商、综合平台服务和潜在客户生成。该公司为消费者提供补贴和非补贴的移动虚拟网络运营商，通过移动宽带服务提供互联网连接；为便利店提供 ACH 银行关系和金融科技交易平台；提供无线充值交易和无线产品聚合；以及主要为大规模侵权行业的律师事务所提供潜在客户生成和案件管理解决方案，以及呼叫中心活动。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过 SurgePays</li>
<li>初学者如何阅读股票图表</li>
<li>Beyond Meat 在迷因股票激增后是否值得购买？分析师表示不值得</li>
<li>10 美元以下的最佳股票</li>
<li>ABBV 股票：250 美元可能是大 Q3 财报超预期后的新底线</li>
<li>外汇是什么，如何运作？</li>
<li>超级微型公司的关键时刻：一个承压的增长故事</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 SurgePays 吗？</h2>
<p>在你考虑 SurgePays 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 SurgePays 并不在名单上。</p>
<p>虽然 SurgePays 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

SURG

<p>SurgePays, Inc. (NASDAQ:SURG) 的空头头寸显著下降，至 10 月 15 日减少了 42.1%，降至 163,900 股。这一减少反映了公司约 1.3% 的股票被卖空，基于 118,900 股的平均日交易量，覆盖天数比率为 1.4 天。该股票下跌 2.9%，报$2.64，市值为 5394 万美元，市盈率为-1.06。分析师的评级不一，平均目标价为$9.50，尽管近期表现存在问题，但仍显示出潜在的增长空间</p>

<p>SurgePays, Inc. (NASDAQ:SURG - Get Free Report) saw a large decrease in short interest during the month of October. As of October 15th, there was short interest totaling 163,900 shares, a decrease of 42.1% from the September 30th total of 282,900 shares. Currently, 1.3% of the shares of the stock are sold short. Based on an average trading volume of 118,900 shares, the short-interest ratio is currently 1.4 days. Based on an average trading volume of 118,900 shares, the short-interest ratio is currently 1.4 days. Currently, 1.3% of the shares of the stock are sold short.</p>
<div class="lb-trans"><p>SurgePays, Inc.（纳斯达克代码：SURG - 获取免费报告）在十月份的空头头寸大幅减少。截至 10 月 15 日，空头头寸总计为 163,900 股，较 9 月 30 日的 282,900 股减少了 42.1%。目前，该股票的 1.3% 股份被做空。根据 118,900 股的平均交易量，当前的空头头寸比率为 1.4 天。</p>
</div><h2>SurgePays Trading Down 2.9%</h2>
<div class="lb-trans"><h2>SurgePays 股价下跌 2.9%</h2>
</div><ul>
<li>Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell</li>
</ul>
<div class="lb-trans"><ul>
<li>便士股票 SurgePays 上涨 70%：买入的一个理由，卖出的五个理由</li>
</ul>
</div><p>Shares of SurgePays stock traded down $0.08 during mid-day trading on Friday, hitting $2.64. The stock had a trading volume of 95,430 shares, compared to its average volume of 107,193. The firm has a 50-day moving average of $2.79 and a two-hundred day moving average of $2.83. SurgePays has a 12-month low of $1.05 and a 12-month high of $3.47. The company has a quick ratio of 0.84, a current ratio of 1.11 and a debt-to-equity ratio of 101.87. The firm has a market cap of $53.94 million, a P/E ratio of -1.06 and a beta of 0.43.</p>
<div class="lb-trans"><p>SurgePays 股票在周五的午盘交易中下跌了 0.08 美元，跌至 2.64 美元。该股票的交易量为 95,430 股，而其平均交易量为 107,193 股。该公司的 50 日移动平均线为 2.79 美元，200 日移动平均线为 2.83 美元。SurgePays 的 12 个月低点为 1.05 美元，12 个月高点为 3.47 美元。该公司的速动比率为 0.84，流动比率为 1.11，债务股本比率为 101.87。该公司的市值为 5394 万美元，市盈率为-1.06，贝塔值为 0.43。</p>
</div><p>SurgePays (NASDAQ:SURG - Get Free Report) last posted its quarterly earnings results on Wednesday, August 13th. The medical equipment provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.31) by ($0.05). SurgePays had a negative net margin of 133.85% and a negative return on equity of 333.87%. The firm had revenue of $11.52 million during the quarter, compared to analysts' expectations of $16.14 million. SurgePays has set its FY 2025 guidance at EPS. Sell-side analysts forecast that SurgePays will post -1.66 earnings per share for the current year.</p>
<div class="lb-trans"><p>SurgePays（纳斯达克代码：SURG - 获取免费报告）最近一次发布季度财报是在 8 月 13 日。该医疗设备提供商报告的每股收益为（0.36 美元），低于市场共识预期的（0.31 美元），差距为（0.05 美元）。SurgePays 的净利润率为负 133.85%，股本回报率为负 333.87%。该公司在本季度的收入为 1152 万美元，而分析师预期为 1614 万美元。SurgePays 已将其 2025 财年的每股收益指引设定为负值。卖方分析师预测 SurgePays 在当前年度的每股收益将为-1.66 美元。</p>
</div><h2>Institutional Trading of SurgePays</h2>
<div class="lb-trans"><h2>SurgePays 的机构交易</h2>
</div><p>Several hedge funds have recently made changes to their positions in the company. James Investment Research Inc. grew its stake in shares of SurgePays by 71.1% in the 3rd quarter. James Investment Research Inc. now owns 32,500 shares of the medical equipment provider's stock valued at $91,000 after buying an additional 13,500 shares during the period. Gerber LLC purchased a new stake in shares of SurgePays in the 3rd quarter valued at approximately $38,000. Jane Street Group LLC purchased a new stake in shares of SurgePays in the 2nd quarter valued at approximately $42,000. NewEdge Advisors LLC boosted its position in shares of SurgePays by 46.2% during the 2nd quarter. NewEdge Advisors LLC now owns 19,000 shares of the medical equipment provider's stock worth $59,000 after purchasing an additional 6,000 shares during the period. Finally, XTX Topco Ltd purchased a new position in shares of SurgePays during the 2nd quarter worth approximately $125,000. Hedge funds and other institutional investors own 6.94% of the company's stock.</p>
<div class="lb-trans"><p>几家对冲基金最近对该公司的持仓进行了调整。James Investment Research Inc.在第三季度将其在 SurgePays 的股份增加了 71.1%。James Investment Research Inc.目前拥有 32,500 股该医疗设备提供商的股票，价值 91,000 美元，此前在此期间又购买了 13,500 股。Gerber LLC 在第三季度购买了 SurgePays 的新股份，价值约 38,000 美元。Jane Street Group LLC 在第二季度购买了 SurgePays 的新股份，价值约 42,000 美元。NewEdge Advisors LLC 在第二季度将其在 SurgePays 的持仓增加了 46.2%。NewEdge Advisors LLC 目前拥有 19,000 股该医疗设备提供商的股票，价值 59,000 美元，此前在此期间又购买了 6,000 股。最后，XTX Topco Ltd 在第二季度购买了 SurgePays 的新股份，价值约 125,000 美元。对冲基金和其他机构投资者持有该公司 6.94% 的股份。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of equities research analysts have recently issued reports on SURG shares. Weiss Ratings restated a &#34;sell (e+)&#34; rating on shares of SurgePays in a research report on Wednesday, October 8th. Ascendiant Capital Markets increased their price target on SurgePays from $9.00 to $9.50 and gave the company a &#34;buy&#34; rating in a report on Friday, October 3rd. Finally, Wall Street Zen raised SurgePays from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, August 30th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of &#34;Hold&#34; and an average target price of $9.50.</p>
<div class="lb-trans"><p>一些股票研究分析师最近对 SURG 股票发布了报告。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 SurgePays 的 “卖出（e+）” 评级。Ascendiant Capital Markets 在 10 月 3 日的报告中将 SurgePays 的目标价从 9.00 美元上调至 9.50 美元，并给予该公司 “买入” 评级。最后，Wall Street Zen 在 8 月 30 日的报告中将 SurgePays 的评级从 “卖出” 上调至 “持有”。一位研究分析师对该股票给予了买入评级，另一位则给予了卖出评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “持有”，平均目标价为 9.50 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on SURG</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 SURG 股票分析</strong></p>
</div><h2>SurgePays Company Profile</h2>
<div class="lb-trans"><h2>SurgePays 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.</p>
<div class="lb-trans"><p>SurgePays, Inc 及其子公司在美国作为一家金融科技和电信公司运营。它通过三个部门运营：移动虚拟网络运营商、综合平台服务和潜在客户生成。该公司为消费者提供补贴和非补贴的移动虚拟网络运营商，通过移动宽带服务提供互联网连接；为便利店提供 ACH 银行关系和金融科技交易平台；提供无线充值交易和无线产品聚合；以及主要为大规模侵权行业的律师事务所提供潜在客户生成和案件管理解决方案，以及呼叫中心活动。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than SurgePays</li>
<li>How to Read Stock Charts for Beginners</li>
<li>Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No</li>
<li>Best Stocks Under $10.00</li>
<li>ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat</li>
<li>What is Forex and How Does it Work?</li>
<li>Super Micro's Moment of Truth: A Growth Story Under Pressure</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 SurgePays</li>
<li>初学者如何阅读股票图表</li>
<li>Beyond Meat 在迷因股票激增后是否值得购买？分析师表示不值得</li>
<li>10 美元以下的最佳股票</li>
<li>ABBV 股票：250 美元可能是大 Q3 财报超预期后的新底线</li>
<li>外汇是什么，如何运作？</li>
<li>超级微型公司的关键时刻：一个承压的增长故事</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in SurgePays Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 SurgePays 吗？</h2>
</div><p>Before you consider SurgePays, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 SurgePays 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 SurgePays 并不在名单上。</p>
</div><p>While SurgePays currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 SurgePays 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

SurgePays, Inc.（NASDAQ 代码：SURG）的空头头寸减少了 42.1%